Leerink Starts Phathom Pharmaceuticals (PHAT) at Market Perform
Tweet Send to a Friend
Leerink analyst Daniel Clark initiates coverage on Phathom Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
